NCT07030101View on ClinicalTrials.gov

A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

282

Participants

Timeline

Start Date

March 31, 2026

Primary Completion Date

February 28, 2029

Study Completion Date

September 30, 2029

Conditions

Hypertension

Interventions

DRUG

TCA108

TCA108

DRUG

Bramicar HCT

Bramicar HCT

Sponsors

Lead Sponsor

All Listed Sponsors

lead

EMS

INDUSTRY